Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-20-002023
Filing Date
2020-10-13
Accepted
2020-10-13 17:15:31
Documents
1
Period of Report
2020-10-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 6624
  Complete submission text file 0001593968-20-002023.txt   7987
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Issuer) CIK: 0001771917 (see all company filings)

EIN.: 270605902 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KARUNA THERAPEUTICS, INC. 33 ARCH STREET, SUITE 3110 BOSTON MA 02110
Business Address
Miller Andrew Craig (Reporting) CIK: 0001777760 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38958 | Film No.: 201237331